Delivery Order SPE2DR25D2009-SPE2DR26FJ3R4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections with a completion date of December 2, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under the company's existing indefinite delivery contract (IDC) with DLA Troop Support Medical. Performance will be executed from AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections with a ceiling value of $77,518.39. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2025, was competitively awarded with no set-aside designation. The pharmaceutical product will be sourced from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency (DLA) awarded a $13,313.09 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, meaning it was competitively awarded. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.62 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pen injectors on December 2, 2025, with a completion date of December 3, 2025. This competitively awarded, firm fixed-price delivery order represents a pharmaceutical supply requirement for the federal healthcare system. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,953.12 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on November 24, 2025, with an ultimate completion date of November 25, 2025. This contract utilizes firm fixed pricing with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound 7.5 mg/0.5 ml pen injections valued at $9,805.19 on May 30, 2025, with completion scheduled for June 2, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for $3,431.61 on August 21, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injectors. This firm fixed-price, non-set-aside delivery order is scheduled for completion by August 22, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction under AmerisourceBergen's larger relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of Zepbound 7.5 mg/0.5 ml pen injections, with a contract ceiling value of $4,637.60. This is a firm fixed-price delivery order with an ultimate completion date of November 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used in this competitive award, indicating the contract was open to all qualified...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.29 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injectors on September 26, 2025, with completion expected by September 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $16,711.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injectors on December 9, 2025, with an ultimate completion date of December 10, 2025. This competitive delivery order, executed under a firm fixed-price contract structure, represents a continuation of pharmaceutical supply fulfillment through AmerisourceBergen's existing relationship with DLA. The product will be delivered to AmerisourceBergen's...
- SPE2DR25D2009Indefinite Delivery Contract
- SPE2DR25D2009-SPE2DR26FJ3R4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,059.05 to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pen injections. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitive award to support federal pharmaceutical procurement needs. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with a completion date of December 2, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's significant market presence as a major pharmaceutical distributor and the extensive scope of its federal contract portfolio demonstrate its capability to fulfill critical medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/30/25 |